What are your peers saying about 1stOncology?
One of the top three Japanese big pharma companies benchmarked 1stOncology across all the major services and reported that 1stOncology has the best coverage and analysis of immunecheckpoint inhibitors and combination therapies.
Big Pharma Client Japan
1stOncology has really been great and very helpful for our BD team
World-leader in Dx/CDx
This is so convenient to do analysis systematically and comprehensively, it works very well! I really appreciate all your time and effort in adding this super feature to your insight tool!
Innovative Asian biotech company
Outstanding service provided by the 1stOncology database!
Global leader in in-vitro diagnostics
Two top tier universities in the US expressed that 1stOncology lets them present the competitive landscape in a very novel and insightful way which differentiate their projects to investors and potential licensing partners
Top Tier Universities
We have many CI tools, but we always turn to 1stOncology when analyzing oncology
Established European Biotech
Very happy with the database which provides many useful details, and we believe your database is significantly better than other databases we have tried out.
Emerging Scandinavian Biotech
Previous
Next
A Trusted Partner
With more than two decades of experience, we are proud to count some of the world largest pharma companies as our longest standing customers, with 15 years or more of collaboration.
More than 70,000 Followers
More than 70,000 other Life Science Professionals are following our 1stOncologyWeekly newsletter
Our Service Guarantee
Unlimited support for your research from our experienced analysts dedicated to the field of cancer drug development.
A Top 10 Global Pharma Analytic Provider
"Our mission is to deliver a superior intelligence service to cancer drug stakeholders and to make 1stOncology the go- to solution for those who are serious about their investment in oncology"
Insights You Can Trust
Since 1999, we have been 100% dedicated and focused on oncology and for 25 years now, we have provided our world-wide client base with the scientific and business insights required for time-saving and accurate analysis of competing drug development and corporate strategies.
The 1stOncology™ Service Guarantee
Unlimited support for your research from our experienced analysts dedicated to the field of cancer drug development.
